Excellos Announces Strategic Partnership and Investment from Vitalant

Strategic Partnership With Vitalant to Bring Better Therapies to Patients

Partnership to deliver enhanced donor profiles for higher potency cell therapeutics

SAN DIEGO. CA, January 17, 2024, – Excellos Inc., a cell therapy contract and development manufacturing organization (CDMO), today announced a new partnership with Vitalant, one of the nation’s largest nonprofit blood and biotherapies healthcare organizations. The strategic partnership includes an investment by Vitalant, and cell sourcing, testing and laboratory services. It also includes collaboration with the Vitalant Innovation Center, which provides scientific research and translational development expertise to bring new products and services to patients across the country.

The strategic partnership is focused on supporting organizations to develop and deliver new cell therapies and addresses major challenges in bringing therapies to patients.

The strategic partnership is focused on supporting organizations to develop and deliver new cell therapies and addresses major challenges in bringing therapies to patients. Cell therapy development teams will now have access to larger and better geographically distributed donors that are well-characterized for aspects including metabolic and effector function profiles. This improves therapeutic potency and reduces manufacturing costs, while reducing clinical response variability.

Commenting on the partnership, David Wellis, Ph.D., Chief Executive Officer of Excellos, said, “This is a great opportunity for Excellos to extend its collection network across the country and to collaborate with Vitalant in several areas, including testing services and research and development at their state-of-the-art Innovation Center. Additionally, Vitalant’s investment brings financial capital to accelerate the launch of new Excellos products and services, including donor characterization through our Excellos 360 platform.”

“This is a great opportunity for Excellos to extend its collection network across the country and to collaborate with Vitalant in several areas, including testing services and research and development at their state-of-the-art Innovation Center.”
David Wellis, CEO of Excellos

“Through our partnership with Excellos and other innovators, Vitalant can leverage our unique capabilities and expertise to transform healthcare,” said Becky Cap, Vitalant’s Senior Vice President of Biotherapies. “We look forward to working with Excellos to help develop new technologies and therapies that improve patient access and outcomes.”

“We look forward to working with Excellos to help develop new technologies and therapies that improve patient access and outcomes.”
Becky Cap, SVP of Biotherapies at Vitalant

About Vitalant
Vitalant is one of the nation’s largest nonprofit blood and biotherapautics healthcare organizations, providing hospitals an patients across the U.S. a safe blood supply, specialized laboratory services, transfusion medicine expertise and world-renowned research. Learn more about our healthcare solutions at www.vitalanthealth.org.

About Excellos
Excellos provides custom cGMP services to develop and manufacture cell therapies. Featuring proprietary cell characterization technologies, Excellos reduces variabilities in clinical responses and increases the probability of successful outcomes. Current applications support TIL-based therapies, autologous and allogenic CAR-T/NK therapies and TCR therapies. Customized services include donor recruitment, cell isolation, transduction, expansion and scale up GMP production.  Learn more at www.excellos.com.

Cell therapy development teams will now have access to larger and better geographically distributed donors that are well-characterized for aspects including metabolic and effector function profiles. This improves therapeutic potency and reduces manufacturing costs, while reducing clinical response variability.

 

Excellos Media Contact
Marianne Woodard
Press and Project Specialist
marianne.woodard@brainspores.com
+1 408-313-8583

Read more about Excellos services here, and contact us to discuss what we can do for you.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

Excellos at Advanced Therapies Week 2024

Autoimmune Therapy Excitement Builds at Advanced Therapies Week 2024

Excellos and Vitalant strategic partnership

Excellos Announces Strategic Partnership and Investment from Vitalant